Tue, February 2, 2021
Mon, February 1, 2021
Sun, January 31, 2021

Ken Cacciatore Maintained (ARQT) at Buy with Increased Target to $80 on, Feb 1st, 2021

Ken Cacciatore of Cowen & Co., Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Increased Target from $55 to $80 on, Feb 1st, 2021.

Ken has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with Ken's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ken


  • Graig Suvannavejh of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $36 on, Monday, November 9th, 2020
  • Gregg Gilbert of "Truist Securities" Initiated at Strong Buy and Held Target at $38 on, Thursday, October 8th, 2020